Submission Details
| 510(k) Number | K182362 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | August 30, 2018 |
| Decision Date | May 23, 2019 |
| Days to Decision | 266 days |
| Submission Type | Traditional |
| Review Panel | Anesthesiology (AN) |
| Summary | Summary PDF |
K182362 is an FDA 510(k) clearance for the MaxCap Ped and MaxCap Neo, a Analyzer, Gas, Carbon-dioxide, Gaseous-phase (Class II — Special Controls, product code CCK), submitted by Maxtec, LLC (Salt Lake City, US). The FDA issued a Cleared decision on May 23, 2019, 266 days after receiving the submission on August 30, 2018. This device falls under the Anesthesiology review panel. Regulated under 21 CFR 868.1400.
| 510(k) Number | K182362 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | August 30, 2018 |
| Decision Date | May 23, 2019 |
| Days to Decision | 266 days |
| Submission Type | Traditional |
| Review Panel | Anesthesiology (AN) |
| Summary | Summary PDF |
| Product Code | CCK — Analyzer, Gas, Carbon-dioxide, Gaseous-phase |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 868.1400 |